deflazacort has been researched along with Muscular Dystrophies in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (50.00) | 18.2507 |
| 2000's | 4 (40.00) | 29.6817 |
| 2010's | 1 (10.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Angelini, C; Astrea, G; Balottin, U; Battini, R; Bello, L; Berardinelli, A; Brighina, E; Catteruccia, M; Civati, F; Colia, G; D'Amico, A; D'Angelo, MG; Gaiani, A; Lombardo, ME; Magliano, L; Messina, S; Motta, MC; Pane, M; Patalano, M; Politano, L; Ricci, G; Sagliocchi, A; Scalise, R; Scutifero, M; Semplicini, C; Sframeli, M; Vita, G; Zaccaro, A | 1 |
| Anderson, JE; Vargas, C | 1 |
| Anderson, JE; Archer, J; Bertrand, A; Grisoni, K; Ségalat, L; Vargas, C | 1 |
| Anderson, JE; Archer, JD; Vargas, CC | 1 |
| Angelini, C; Costa, C; Intino, MT; Pegoraro, E; Pini, A; Turella, E | 1 |
| Reitter, B | 1 |
| Angelini, C; Duggan, DJ; Fanin, M; Freda, MP; Hoffman, EP; Menegazzo, E | 1 |
| Escolar, DM; Scacheri, CG | 1 |
| Corderi, J; Dubrovsky, AL; Flores, D; Marco, P; Mesa, LE | 1 |
1 review(s) available for deflazacort and Muscular Dystrophies
| Article | Year |
|---|---|
Pharmacologic and genetic therapy for childhood muscular dystrophies.
Topics: Animals; Cell Transplantation; Child; Child, Preschool; Clinical Trials as Topic; Creatine; Cytoskeletal Proteins; Drug Administration Schedule; Dystrophin; Female; Gene Expression Regulation; Genetic Therapy; Genetic Vectors; Humans; Male; Membrane Proteins; Mice; Mice, Inbred mdx; Muscle, Skeletal; Muscular Dystrophies; Muscular Dystrophy, Animal; Muscular Dystrophy, Duchenne; Prednisone; Pregnenediones; Protein Biosynthesis; Sarcolemma; Utrophin | 2001 |
3 trial(s) available for deflazacort and Muscular Dystrophies
| Article | Year |
|---|---|
Deflazacort in Duchenne dystrophy: study of long-term effect.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Body Weight; Child; Double-Blind Method; Follow-Up Studies; Gait; Humans; Motor Activity; Muscles; Muscular Dystrophies; Patient Dropouts; Pregnenediones; Time Factors | 1994 |
Deflazacort vs. prednisone in Duchenne muscular dystrophy: trends of an ongoing study.
Topics: Alkaline Phosphatase; Anti-Inflammatory Agents; Body Weight; Child; Child, Preschool; Creatine Kinase; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Male; Muscle Contraction; Muscular Dystrophies; Neurology; Prednisone; Pregnenediones | 1995 |
Steroids in Duchenne muscular dystrophy--deflazacort trial.
Topics: Anti-Inflammatory Agents; Child; Child, Preschool; Double-Blind Method; Humans; Muscular Dystrophies; Prednisolone; Pregnenediones | 1991 |
6 other study(ies) available for deflazacort and Muscular Dystrophies
| Article | Year |
|---|---|
Integrated care of muscular dystrophies in Italy. Part 1. Pharmacological treatment and rehabilitative interventions.
Topics: Adolescent; Age Factors; Bone Density Conservation Agents; Breathing Exercises; Cardiotonic Agents; Child; Combined Modality Therapy; Dietary Supplements; Disability Evaluation; Female; Glucocorticoids; Health Care Surveys; Humans; Italy; Male; Muscular Dystrophies; Physical Therapy Modalities; Prednisone; Pregnenediones; Respiration, Artificial; Time Factors | 2017 |
Correlated NOS-Imu and myf5 expression by satellite cells in mdx mouse muscle regeneration during NOS manipulation and deflazacort treatment.
Topics: Animals; Anti-Inflammatory Agents; Arginine; Blotting, Northern; Diaphragm; DNA-Binding Proteins; Dystrophin; Immunosuppressive Agents; In Situ Hybridization; Mice; Mice, Inbred mdx; Muscle Fibers, Skeletal; Muscle Proteins; Muscle, Skeletal; Muscular Dystrophies; Myogenic Regulatory Factor 5; Nitric Oxide Synthase; Pregnenediones; Protein Isoforms; Proto-Oncogene Proteins c-fos; Proto-Oncogene Proteins c-met; Regeneration; RNA, Messenger; Satellite Cells, Skeletal Muscle; Trans-Activators | 2003 |
CAPON expression in skeletal muscle is regulated by position, repair, NOS activity, and dystrophy.
Topics: Adaptor Proteins, Signal Transducing; Animals; Arginine; Blotting, Western; Diaphragm; Dystrophin; Immunohistochemistry; Immunosuppressive Agents; In Situ Hybridization; Laminin; Mice; Mice, Inbred C57BL; Mice, Inbred mdx; Muscle, Skeletal; Muscular Dystrophies; Nitric Oxide Synthase; Pregnenediones; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Satellite Cells, Skeletal Muscle; Time Factors; Utrophin | 2005 |
Persistent and improved functional gain in mdx dystrophic mice after treatment with L-arginine and deflazacort.
Topics: Animals; Anti-Inflammatory Agents; Arginine; Drug Therapy, Combination; Gene Expression Regulation; Mice; Mice, Inbred mdx; Muscle Fibers, Skeletal; Muscle, Skeletal; Muscular Dystrophies; Myogenic Regulatory Factor 5; NG-Nitroarginine Methyl Ester; Pregnenediones | 2006 |
47th ENMC International Workshop: Treatment of Muscular Dystrophy. 13-15 December 1996, Naarden, The Netherlands.
Topics: Anti-Inflammatory Agents; Humans; Muscular Dystrophies; Prednisolone; Pregnenediones | 1997 |
Homozygous alpha-sarcoglycan mutation in two siblings: one asymptomatic and one steroid-responsive mild limb-girdle muscular dystrophy patient.
Topics: Adult; Anti-Inflammatory Agents; Biomarkers; Biopsy; Blotting, Western; Creatine Kinase; Cytoskeletal Proteins; Dystroglycans; Female; Humans; Immunohistochemistry; Male; Membrane Glycoproteins; Muscle, Skeletal; Muscular Dystrophies; Pedigree; Polymerase Chain Reaction; Pregnenediones; Sarcoglycans; Tomography, X-Ray Computed; Transcription, Genetic | 1998 |